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Introduction: Infections remain a major cause of morbidity and mortality in immunocompromised patients and
require early diagnosis and treatment. However, correct diagnosis and treatment are often delayed by a multitude
of factors. We report what we believe to be the first case of a combined disseminated infection with Nocardia and
Mucor in a patient with systemic lupus erythematosus.
Case presentation: A 74-year-old Caucasian woman with systemic lupus erythematosus presented with recurrent
pneumonia. Despite empirical treatment with antibiotics, her condition gradually deteriorated. Microbiological
sampling by thoracoscopy revealed the presence of Nocardia. Despite the institution of therapy for disseminated
nocardiosis, she died of multi-organ failure. A post-mortem investigation confirmed nocardiosis, but showed
concomitant disseminated mucormycosis infection as well.
Conclusion: Members of the bacterial genus Nocardia and the fungal genus Mucor are ubiquitous in the
environment, have the ability to spread to virtually any organ, and are remarkably resistant to appropriate therapy.
Both pathogens can mimic other pathologies both on clinical and radiological investigations. Invasive sampling
procedures are often needed to prove their presence. Establishing a timely, correct diagnosis and a specific
treatment is essential for patient survival.
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Infections remain a major cause of morbidity and mortal-
ity in patients with systemic lupus erythematosus (SLE).
These patients are at increased risk for bacterial and op-
portunistic infections due to intrinsic and extrinsic im-
munosuppression [1].
Nocardia species and Mucorales are ubiquitous in na-
ture and can be found in soil, water and decaying matter
[2-4]. The genus Nocardia belongs to a group of Gram-
positive, aerobic bacteria characterized by branching,
filamentous cells [2].
Mucormycosis is a fungal infection caused by members
of the Mucorales, belonging to the phylum Zygomycota [3].* Correspondence: frederik.declerck@ugent.be
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with right-angled branching [4]. Mucorales have a charac-
teristic tendency to invade blood vessels, causing tissue in-
farction, hemorrhage and necrosis [3,4]. Nocardia and
Mucorales enter the body by direct inoculation of the skin
after trauma or by inhalation [1,3,5]. Up to one third of
Nocardia infections occur in the immunocompetent host
[1,2], in contrast to Mucorales infections, which rarely
occur in this population [4].Case presentation
A 74-year-old Caucasian woman presented to our emer-
gency department in May 2013 with severe exertional
dyspnea. She was known to have SLE and Sjögren’s syn-
drome, diagnosed in 1985. Her treatment consisted of
hydroxychloroquine, which was then switched to low-
dose oral prednisolone because of retinopathy. She wasal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 High-resolution computed tomography showing
mildly enlarged lymph nodes, mostly right-sided pleural
lesions, thickening of the fissures and interlobular septa,
and bilateral diffuse micronodular opacities (miliary pattern).
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before admission. From then on, she was hospitalized
several times because of presumed respiratory infection,
which temporarily responded to repeated courses of em-
pirical antibiotic treatment.
Three months before admission, a computed tomog-
raphy (CT) scan of her chest showed a mild pericardial
and right-sided pleural effusion, ruling out pulmonary
embolism and lung parenchymal abnormalities. Echocar-
diography showed concentric biventricular hypertrophic
cardiomyopathy. A month later, she presented with atrial
fibrillation and chest pain with elevated cardiac enzymes.
We made a diagnosis of SLE perimyocarditis and started
treatment with 32mg of methylprednisolone once a day
combined with 100 mg of azathioprine once a day. A few
weeks later, she was hospitalized because of another pneu-
monia of her right lower lobe. She was empirically treated
with moxifloxacin. After an initial improvement she was
discharged, but after a short period she presented again at
our emergency department with severe exertional dys-
pnea, bilateral pleuritic pain, headache, night sweats, fa-
tigue and weight loss.
On admission, her vital signs were normal. Lung aus-
cultation revealed bilateral basal crepitations and there was
mild bimalleolar edema. The most prominent laboratory
findings were a moderate normocytic anemia (hemoglobin
9.7g/dL) and elevated inflammatory parameters (C-reactive
protein 147mg/L; white blood cell count 19760/μL).
Chest radiography showed cardiomegaly, elevation of
her right diaphragm, a right-sided pleural effusion and
small bilateral consolidations. Echocardiography showed
no pericardial effusion. Because of a highly elevated
N-terminal pro-brain natriuretic peptide level (>25,000ng/L),
a diagnosis of global heart failure was made and therapy
was initiated. Because of her long-standing general symp-
toms, blind blood cultures were taken and high-resolution
CT (HRCT) was planned. Two days after admission she
developed fever. At that time, HRCT showed multiple
mildly enlarged lymph nodes. There were multiple pleural
lesions (mostly right-sided), partial compression atelectasis
of her right lobe, a mild right-sided pleural effusion, thick-
ening of the fissures and interlobular septa, and bilateral
diffuse micronodular opacities (miliary pattern) (Figure 1).
Urgent bronchoscopy with bronchoalveolar lavage (BAL)
led to further respiratory distress for our patient, necessi-
tating intensive care unit (ICU) admission. Piperacillin-
tazobactam was empirically started and the BAL results
showed Pseudomonas aeruginosa, susceptible to the initi-
ated antibiotics. Acid-fast stains were repeatedly negative
(BAL and sputum). Four days later, one blood culture
turned positive for Nocardia species. Her antibiotics were
switched to trimethoprim-sulfamethoxazole combined
with piperacillin-tazobactam. Intubation and mechanical
ventilation proved necessary because of further respiratorydeterioration. Given the findings on CT of her thorax,
a diagnostic thoracoscopic lung biopsy was performed,
which showed multiple sub-pleural abscesses. Overnight,
an overwhelming septic shock developed with diffuse
intravascular coagulation, lactic acidosis, liver failure, acute
renal failure with anuria and need for high-dose noradren-
aline. Continuous hemodialysis was started and amikacin
was added to the antibiotics regimen. A CT scan of her
brain, performed because of anisocoria, showed lesions
compatible with abscess formation in her occipitotemporal
area and brainstem. A tracheal aspirate and pleural biopsy
confirmed the presence of massive amounts of Nocardia
without evidence of other co-existing pathology.
Ten days after our patient’s ICU admission she died of
multiple organ failure. To uncover the full extent of the in-
fection, an autopsy was performed. A brain autopsy was re-
fused by the family on emotional grounds. Surprisingly,
multiple abscesses and necrotic areas containing both
Nocardia and Mucorales were detected in both lungs
(Figure 2a), as well as in her heart (endo-, myo- and pericar-
dium and tricuspid valve; Figure 3) and some septal arteries
(Figure 2b). Nocardia was also found in both her kidneys
(Figure 2c) and her intestines. Behind the left lobe of
the thyroid gland an abscess was detected containing
Nocardia. The Nocardia isolate was further identified as
Nocardia farcinica. Identification was obtained on the basis
of sequence determination of the 16S rRNA gene, as de-
scribed previously [6], and by comparison of the sequence
with those obtained in a previous study [7]. Antibiotic sen-
sitivity was tested using the disc diffusion method.
Discussion
In retrospect, these infections probably accounted for
some of the patient’s previous symptoms. This case clearly
Figure 2 Autopsy findings. (a) Mucormycosis in the upper lobe of the left lung. (b) Mucormycosis invading a cardiac artery in the septum.
(c) Nocardia in the glomerulus of the left kidney.
Figure 3 Post-mortem specimen showing abscess formation on
the apex of the heart.
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infections. The differential diagnosis was broad and in-
cluded opportunistic infections, malignancy and interstitial
lung disease. The possibility of an opportunistic infection,
including mucormycosis, tuberculosis, actinomycosis and
nocardiosis, all having similar appearance on CT, ranked
high in the list of possible diagnosis [8]. The presence of
mildly enlarged hilar and mediastinal lymph nodes, as
found in our patient, is unusual in nocardiosis. This find-
ing, together with radiologic signs suggestive of previous
tuberculosis exposure and the clinical presentation of
night sweats and weight loss further complicated the dif-
ferential diagnosis. Pulmonary malignancies and intersti-
tial lung disease, including lupus interstitial pneumonia,
non-specific interstitial pneumonia or co-existing sarcoid-
osis, were also part of the diagnostic spectrum.
Multiple factors contributed to the difficulty of the diag-
nostic process. First, our patient presented with recurrent
acute pulmonary infections with temporary improvement
after treatment with antibiotics, mostly fluoroquinolones.
Fluoroquinolones have activity against Nocardia farcinica
[2]. Second, it took six months to acquire a positive
(blood) culture for Nocardia. The microbiological chal-
lenge is well described in the literature for nocardiosis and
mucormycosis [4,5]. Third, Pseudomonas aeruginosa was
isolated from the BAL and initially deemed responsible for
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heart failure and that the infection mimicked a flare-up of
SLE [9]. Importantly, disease activity and infection can
occur simultaneously [4].
Isolation of Nocardia in any patient, from any body
source, should always be regarded as significant [2]. An
aggressive diagnostic strategy that includes BAL and tis-
sue biopsies may significantly improve the outcome [4].
Rapid identification of infection with Nocardia is cru-
cial, because delayed diagnosis and treatment has an
important impact on the prognosis [9]. Because of the
evolution to septic shock, ceftriaxone and amikacin were
added to our patient’s antibiotic regimen. An optimal anti-
biotic treatment for nocardiosis is not yet established
[2,10]. Trimethoprim-sulfamethoxazole has been the drug
of choice for treatment of nocardiosis for many years
[5,10,11] but there are several other antibiotics with activ-
ity against Nocardia, including ceftriaxone, cefotaxime,
amikacin, imipenem, meropenem, linezolid, minocycline,
moxifloxacin, levofloxacin, tigecycline and amoxicillin-
clavulanic acid [2]. Because there is a difference in antibiotic
susceptibility pattern between Nocardia species, identifica-
tion to the species level and antibiotic susceptibility testing
should, like in our case, be undertaken in each patient and
treatment should be individualized accordingly [2]. Com-
bination therapy with a second or even a third antibiotic
agent in severe cases can be warranted until the suscepti-
bility pattern is known and the clinical condition of the
patient improves [2]. The duration of antibiotic therapy
is often prolonged to minimize disease relapse (6 to
12 months, and in some cases even longer) [2,5,10]. The
mortality rate in immunosuppressed patients with pul-
monary and/or disseminated Nocardia infection is as
high as 65% [11].
Mucormycosis is a very aggressive invasive fungal disease.
When suspected, a biopsy should be obtained whenever
possible. Diagnosis requires direct microscopy, histopath-
ology and culturing of clinical specimens [12]. Unfortu-
nately, the pre-mortem diagnostic rate of mucormycosis is
extremely low [4]. The mainstay of treatment is surgical de-
bridement and treatment with (liposomal) amphotericin B
(at least 5mg/kg/day), or posaconazole (200mg, four times
daily) in case of treatment failure with amphotericin B [12].
A handful of cases of mucormycosis in SLE were re-
ported in the English literature and most of them were
disseminated infections with fatal outcome even if ad-
equate therapy with amphotericin B was initiated [4].
Only a few cases of combined disseminated mucormyco-
sis and nocardiosis in immunosuppressed patients have
been reported [13].
Conclusions
To the best of our knowledge, there have been no previ-
ous cases of combined disseminated nocardiosis andmucormycosis in patients with SLE reported in the lit-
erature. Patients with SLE are at high risk for opportun-
istic infections because of cellular immunosuppression
caused by lupus itself or by its treatment. This case is
another reminder that we should expect the unexpected
(pathogen) in the immunocompromised patient. Both
nocardiosis and mucormycosis may mimic other path-
ologies, on clinical as well as radiological examination.
Invasive sampling procedures are often needed to prove
infection. Establishing a timely diagnosis is challenging
and unfortunately the correct diagnosis is often only made
post-mortem.
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